-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
المؤلفون: Vongsachang H; Ophthalmic Plastic Surgery Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston., Stagner AM; David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear, Harvard Medical School, Boston., Aronow ME; Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston., Wolkow N; Ophthalmic Plastic Surgery Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston.; David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear, Harvard Medical School, Boston.
المصدر: JAMA ophthalmology [JAMA Ophthalmol] 2023 Aug 01; Vol. 141 (8), pp. 801-803.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE
مواضيع طبية MeSH: Macular Degeneration*/drug therapy , Wet Macular Degeneration*/drug therapy , Choroidal Neovascularization*/drug therapy, Humans ; Endothelial Growth Factors/therapeutic use ; Ranibizumab/therapeutic use ; Angiogenesis Inhibitors/therapeutic use ; Intravitreal Injections ; Retrospective Studies
SCR Disease Name: Uveal melanoma
-
6دورية أكاديمية
المؤلفون: Liberman P; Division of Ocular Immunology, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Departamento de Oftalmología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile., Francis JH; Ocular Oncology Service, Memorial Sloan Kettering, New York, New York, USA., Mehrotra K; Division of Ocular Immunology, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Tian J; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., McGarrey MP; Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA., Sobol EK; Ocular Oncology Service, Memorial Sloan Kettering, New York, New York, USA., Thorne JE; Division of Ocular Immunology, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Aronow ME; Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA., Berkenstock MK; Division of Ocular Immunology, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
المصدر: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2023 Apr; Vol. 31 (3), pp. 496-500. Date of Electronic Publication: 2022 Feb 24.
نوع المنشور: Observational Study; Multicenter Study; Journal Article
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-5078 (Electronic) Linking ISSN: 09273948 NLM ISO Abbreviation: Ocul Immunol Inflamm Subsets: MEDLINE
مواضيع طبية MeSH: Macular Edema*/surgery , Retinal Neoplasms*/diagnosis , Retinal Neoplasms*/surgery , Lymphoma*, Humans ; Vitreous Body/surgery ; Retrospective Studies ; Neoplasm Recurrence, Local/surgery ; Vitrectomy
-
7Editorial & Opinion
المؤلفون: Trofimov AV; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Aronow ME; Ocular Melanoma Center, Massachusetts Eye and Ear, Boston, Massachusetts; ***Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts., Bussière MR; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; *Harvard Medical School, Boston, Massachusetts., Gragoudas ES; Ocular Melanoma Center, Massachusetts Eye and Ear, Boston, Massachusetts; *Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts., Keane FK; *Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; **Harvard Medical School, Boston, Massachusetts., Kim IK; *Ocular Melanoma Center, Massachusetts Eye and Ear, Boston, Massachusetts; **Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts., Shih HA; **Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; ***Harvard Medical School, Boston, Massachusetts., Bhagwat MS; ***Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; ****Harvard Medical School, Boston, Massachusetts.
المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2023 Mar 01; Vol. 115 (3), pp. 810-811.
نوع المنشور: Letter
بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: PubMed not MEDLINE; MEDLINE
-
8دورية أكاديمية
المؤلفون: Uner OE; Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon., Aronow ME; Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts., Mruthyunjaya P; Department of Ophthalmology, Byers Eye Institute, Stanford School of Medicine, Palo Alto, California., Materin MA; Department of Ophthalmology, Duke University Eye Center, Durham, North Carolina; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina., Stacey AW; Department of Ophthalmology, University of Washington, Seattle, Washington., Wilson M; Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, Tennessee; Ocular Oncology Division, St. Jude Children's Research Hospital, Memphis, Tennessee., Afshar A; Ocular Oncology Service, Department of Ophthalmology, Wayne & Gladys Valley Center for Vision, University of California, San Francisco, San Francisco, California., Skalet AH; Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon; Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon; Department of Dermatology, Oregon Health & Science University, Portland, Oregon. Electronic address: skalet@ohsu.edu.
المصدر: Ophthalmology. Retina [Ophthalmol Retina] 2023 Mar; Vol. 7 (3), pp. 284-286. Date of Electronic Publication: 2022 Oct 29.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: Published by Elsevier Inc. on behalf of American Academy of Ophthalmology Country of Publication: United States NLM ID: 101695048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-6530 (Electronic) Linking ISSN: 24686530 NLM ISO Abbreviation: Ophthalmol Retina Subsets: MEDLINE
مواضيع طبية MeSH: Melanoma* , Uveal Neoplasms*, Humans ; Registries
SCR Disease Name: Uveal melanoma
-
9دورية أكاديمية
المؤلفون: Trofimov AV; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: atrofimov@mgh.harvard.edu., Aronow ME; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts., Gragoudas ES; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts., Keane FK; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Kim IK; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts., Shih HA; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Bhagwat MS; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2023 Feb 01; Vol. 115 (2), pp. 501-510. Date of Electronic Publication: 2022 Jul 22.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE
مواضيع طبية MeSH: Brachytherapy*/methods , Proton Therapy* , Eye Neoplasms*/radiotherapy , Eye Neoplasms*/pathology , Melanoma*/radiotherapy , Melanoma*/pathology, Humans ; Protons ; Radiotherapy Dosage
-
10دورية أكاديمية
المؤلفون: Lane AM; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts., Oxenreiter MM; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts., Hashmi M; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts., Aronow ME; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts., Trofimov AV; Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts., Shih HA; Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts., Gragoudas ES; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts., Kim IK; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts. Electronic address: ivana_kim@meei.harvard.edu.
المصدر: Ophthalmology. Retina [Ophthalmol Retina] 2022 Nov; Vol. 6 (11), pp. 1089-1097. Date of Electronic Publication: 2022 May 16.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Published by Elsevier Inc. on behalf of American Academy of Ophthalmology Country of Publication: United States NLM ID: 101695048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-6530 (Electronic) Linking ISSN: 24686530 NLM ISO Abbreviation: Ophthalmol Retina Subsets: MEDLINE
مواضيع طبية MeSH: Protons* , Melanoma*, Humans ; Neoplasm Recurrence, Local ; Retrospective Studies ; Treatment Outcome
SCR Disease Name: Uveal melanoma